Patent intelligence · US
US 10265396
Magnetic extracellular matrix
Magnetic extracellular matrix
Patent details — US 10265396
- Jurisdiction
- US
- Status
- granted
- Grant date
- Apr 23, 2019
- Expiration
- Apr 18, 2039
- Applicant
- GREINER BIO-ONE NORTH AMERICA, INC.
- Claims
- 10
- CPC classes
- A61K, A61K41/0052, A61P, A61P43/00
Quick answer
US 10265396 (Magnetic extracellular matrix) is held by GREINER BIO-ONE NORTH AMERICA, INC.. Status: granted. Granted Apr 23, 2019. Expires Apr 18, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- GREINER BIO-ONE NORTH AMERICA, INC.
- Grant date
- Expiration
- Claims
- 10
- CPC classes
- A61K, A61K41/0052, A61P, A61P43/00
More from GREINER BIO-ONE NORTH AMERICA, INC.
Related pharmaceutical patents in our USPTO index.
-
US 12390512
Depolymerase capable of degrading extracellular polymeric substances of Klebsiella pneumoniae
granted -
US 11033623
Magnetic stem cell therapy for lesions
granted -
US 10472381
Sialic acid derivatives
granted -
US 9539228
Composition containing lysine as a nutritional supplement or treatment in the case of herpes
granted -
US 8309071
Foamy viral envelope genes
granted -
US 8293803
Retinoid compounds and their use
granted -
US 8268792
Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases
granted
Frequently asked questions
What is US patent 10265396?
US 10265396 (Magnetic extracellular matrix) is held by GREINER BIO-ONE NORTH AMERICA, INC.. Status: granted. Granted Apr 23, 2019. Expires Apr 18, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10265396?
GREINER BIO-ONE NORTH AMERICA, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 11 pharmaceutical patents for this assignee.
When does US 10265396 expire?
Our index shows an expiration date of Apr 18, 2039 (13 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.